Nevro Corp. (NVRO) by event type
NVRO moves most on analyst downgrades — a median of +2.36% at 30 minutes across 30 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NVRO overview →
How NVRO reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,092 of 2,717 | 19 | -0.26% | 42% | +0.47% |
| Analyst downgrades 20 of 2,603 | 30 | +2.36% | 57% | +1.73% |
| Rating reiterations 3,384 of 3,522 | 37 | -0.69% | 32% | -0.80% |
| Price-target cuts 750 of 1,527 | 25 | -0.00% | 44% | -0.76% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how NVRO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target cuts → · NVRO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
| DarioHealth Corp. (DRIO) | 252 | 0.00% | 45% |
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.